Anti-heparin-platelet factor 4 antibodies after cardiopulmonary bypass: Role of HLA expression [7]

Haematologica

Volumn 86, Issue 3, 2001, Pages 326-327

  Paparella, D ^a   Micelli, M ^a   Favoino, B ^a   D'Alo M ^a   Fiore, T ^a   De Luca Tupputi Schinosa, L ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cardiopulmonary bypass; Heparin induced thrombocytopenia; HIT; HLA

Indexed keywords

HEPARIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR3 ANTIGEN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; CARDIOPULMONARY BYPASS; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART SURGERY; HLA SYSTEM; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ADULT; AGED; ANTIBODIES; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PLATELET FACTOR 4;

EID: 0035067241     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia
2. Impact of the patient population on the risk of heparin-induced thrombocytopenia
3. Heparin-induced thrombocytopenia
4. Heparin induced thrombocytopenia: Molecular pathogenesis
5. MCH Class-II molecules and autoimmunity
6. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia
7. The genetic basis for the association of the 8.1 ancestral haplotype (A1, BS, DR3) with multiple immunopathological diseases